CAS Investment Partners entered into an agreement with Cardlytics (CDLX)

Key Summary: On June 23, 2023, CAS Investment Partners (16.6%) expressed support for CEO Karim Temsamani, citing his expertise in building growth-oriented tech businesses, and planned to engage with the board to enhance stockholder value. On September 19, 2023, CAS entered a Cooperation Agreement with the company, increasing the board to nine members an…